Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of Fluoroquinolones
Pharmacoepidemiology and Drug Safety · 2024
DOI: 10.1002/pds.70022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Yuchen Guo und 23 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Statistics in Medicine, University of Oxford, Botnar Research Centre, Oxford, UK. Hauptthemen laut MEDLINE: Fluoroquinolones, Primary Health Care, Interrupted Time Series Analysis, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, UKRI Strategic Priority Fund (SPF) - Alleviate Pain Data Hub, Medicines and Healthcare Products Regulatory Agency.
Abstract (Originalsprache)
Purpose
To illustrate the interest in using interrupted time series (ITS) methods, this study evaluated the impact of the UK MHRA's March 2019 Risk Minimisation Measures (RMM) on fluoroquinolone usage.
Methods
Monthly and quarterly fluoroquinolone use incidence rates from 2012 to 2022 were analysed across hospital care (Barts Health NHS Trust), primary care (Clinical Practice Research Datalink (CPRD) Aurum and CPRD GOLD), and linked records from both settings (East Scotland). Rates were stratified by age (19–59 and ≥ 60 years old). Seasonality‐adjusted segmented regression and ARIMA models were employed to model quarterly and monthly rates, respectively.
Results
Post‐RMM, with segmented regression, both age groups in Barts Health experienced nearly complete reductions (> 99%); CPRD Aurum saw 20.19% (19–59) and 19.29% ( 60) reductions; no significant changes in CPRD GOLD; East Scotland had 45.43% (19–59) and 41.47% ( 60) decreases. Slope analysis indicated increases for East Scotland (19–59) and both CPRD Aurum groups, but a decrease for CPRD GOLD's 60; ARIMA detected significant step changes in CPRD GOLD not identified by segmented regression and noted a significant slope increase in Barts Health's 19–59 group. Both models showed no post‐modelling autocorrelations across databases, yet Barts Health's residuals were non‐normally distributed with non‐constant variance.
Conclusions
Both segmented regression and ARIMA confirmed the reduction of fluoroquinolones use after RMM across four different UK primary care and hospital databases. Model diagnostics showed good performance in eliminating residual autocorrelation for both methods. However, diagnostics for hospital databases with low incident use revealed the presence of heteroscedasticity and non‐normal white noise using both methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Statistics in Medicine, University of Oxford, Botnar Research Centre, Oxford, UK.
- Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
- Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Valles), Barcelona, Spain.
- Medicines and Healthcare Products Regulatory Agency, London, UK.
- Barts Bone and Joint Health, Queen Mary University of London, London, UK.
- Barts Health NHS Trust, NHS Trust, London, UK.
ORCID-Profile: Yuchen Guo, Daniel Prieto-Alhambra
Förderung
- Medical Research Council
- UKRI Strategic Priority Fund (SPF) - Alleviate Pain Data Hub
- Medicines and Healthcare Products Regulatory Agency
- NIHR Oxford Biomedical Research Centre
Zitieren
APA
Guo, Y., Raventós, B., Català, M., Elhussein, L., López-Güell, K., Tan, E. H., Prats-Uribe, A., Dedman, D., Man, W. Y., Omulo, H., Delmestri, A., Lane, J. C. E., Rahman, U., Griffin, X. L., Gao, C., Cole, C., Batty, P., Connelly, J., Booth, H., …, & Jödicke, A. M. (2024). Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of Fluoroquinolones. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70022
Vancouver
Guo Y, Raventós B, Català M, Elhussein L, López-Güell K, Tan EH, et al. Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of Fluoroquinolones. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.70022
BibTeX
@article{Guo2024,
author = {Guo, Yuchen and Raventós, Berta and Català, Martí and Elhussein, Leena and López-Güell, Kim and Tan, Eng Hooi and Prats-Uribe, Albert and Dedman, Daniel and Man, Wai Yi and Omulo, Hezekiah and Delmestri, Antonella and Lane, Jennifer C E and Rahman, Usama and Griffin, Xavier L and Gao, Chuang and Cole, Christian and Batty, Patrick and Connelly, John and Booth, Helen and Cave, Alison and Donegan, Katherine and Prieto-Alhambra, Daniel and Burn, Edward and Jödicke, Annika M},
title = {Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of Fluoroquinolones},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2024},
doi = {10.1002/pds.70022}
}
EUVIMED